Open AccessRapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia
Author(s) -
Anne Ricksten,
Lars Palmqvist,
Peter Johansson,
Björn Andréasson
Publication year - 2008
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.12801
Subject(s) - essential thrombocythemia , polycythemia vera , medicine , hydroxycarbamide , myelofibrosis , tyrosine kinase , janus kinase 2 , polycythemia rubra vera , anagrelide , myeloproliferative disorders , myeloproliferative neoplasm , gastroenterology , cancer research , chemotherapy , receptor , bone marrow
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom